Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns - Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY)
Compounding weight loss drugs, which are similar to brand-name medications such as Ozempic and Mounjaro, will be banned in Australia.
Source: benzinga.com